Lawrence Bruno - 31 Jul 2026 Form 4 Insider Report for Core Laboratories Inc. /DE/ (CLB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Aug 2026, 10:40:31 UTC
Prior SEC filing
17 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark Tattoli, Attorney-in-Fact

Key filing fact

Lawrence Bruno filed Form 4 for Core Laboratories Inc. /DE/ (CLB) on 04 Aug 2026.

Key facts

  • This page summarizes Lawrence Bruno's Form 4 filing for Core Laboratories Inc. /DE/ (CLB).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Aug 2026, 10:40.

Change

  • Previous filing in this sequence was filed on 17 Feb 2026.
  • Current net transaction value: +$53,900.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001730336 Primary reporting owner

Bruno Lawrence

Relationship
Chairman and CEO, Director
Address
6316 WINDFERN ROAD, HOUSTON
Signature
/s/ Mark Tattoli, Attorney-in-Fact
Signature date
04 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLB transaction

Common Stock

Purchase

Transaction value
$53,900
Shares
+5,000
Change %
+1.9%
Price
$10.78
Shares after
262,438
Date
31 Jul 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .